Get all premium features to the best stock analysis tool

Voyageur Pharmaceuticals Advances Mueller Iodine Extraction Process with 99.8% Purity Results and Planned Field Pilot Testing

CALGARY, Alberta – August 10, 2026 – TheNewswire - Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC Pink: VYYRF) (“Voyageur” or the “Company”), a Canadian developer of pharmaceutical-grade barium and iodine contrast media for medical imaging, is pleased to provide an update on the advancement of its proprietary patent-pending Mueller iodine extraction process. The Mueller process is being developed to recover high-purity iodine from iodine-rich oilfield brine, supporting Voyageur's strategy to establish a domestic iodine supply for the North American radiology contrast media market, while offering oil and gas producers and midstream water operators a new pathway to generate value from produced brine. Recent laboratory work has successfully produced iodine at 99.8% purity, with overall process recovery exceeding 90%.